Pharmaceutical
Technology
Health

Titan Pharmaceuticals

$1.24
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (3.33%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell TTNP and other stocks, options, ETFs, and crypto commission-free!

About TTNP

Titan Pharmaceuticals, Inc. Common Stock, also called Titan Pharmaceuticals, is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Read More Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.

Employees
23
Headquarters
South San Francisco, California
Founded
1992
Market Cap
16.63M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
211.07K
High Today
$1.24
Low Today
$1.16
Open Price
$1.19
Volume
175.88K
52 Week High
$5.76
52 Week Low
$1.03

Collections

Pharmaceutical
Technology
Health
Biopharmaceutical
Therapy
Medical
US
North America

TTNP Earnings

-$0.34
-$0.24
-$0.14
-$0.04
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 14, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.